Health Library
January 6, 2026
Question on this topic? Get an instant answer from August.

Okokuqala, asicacise amagama. I-Cymbalta igama lomkhiqizo elaziwa kakhulu le dawa ye-generic ebizwa nge-duloxetine. Ngakho-ke, lapho sikhuluma nge-duloxetine uses, sikhuluma ngezakhiwo ezifanayo kanye nezicelo zazo.
Ngakho, ingabe i-Cymbalta yi-SNRI? Yebo, kunjalo. I-Cymbalta ingeyekilasi lama-antidepressants abizwa nge-Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs). Lokhu kungase kubonakale kuyinkimbinkimbi, kodwa umqondo oyinhloko ulula kakhulu. Ubuchopho bakho busebenzisa izithunywa zamakhemikhali ezibizwa nge-neurotransmitters ukuxhumana phakathi kwamajele emithambo. Izithunywa ezimbili ezibalulekile yilezi:
Eziphathelene nezimo ezinjengokudumala, ukukhathazeka, nobuhlungu obungapheli, amazinga alezi neurotransmitters angase angalingani. Ama-SNRI, njenge-Cymbalta, asebenza ngokuvimbela ukumuncwa kabusha (noma i-“reuptake”) kwe-serotonin ne-norepinephrine emajeleni emithambo. Lokhu kushiya kukhona kakhulu la makhemikhali atholakalayo ebuchopho nasemgogodleni, kusiza ukuthuthukisa imizwa, kunciphise ukukhathazeka, nokunciphisa izimpawu zokuhlunga ezihamba emgqeni wezinzwa umthombo.
I-U.S. Food and Drug Administration (FDA) ihlole ngokuqinile futhi yagunyaza i-Cymbalta ukwelapha izimo eziningana zezokwelapha ezihlukene. Lapho udokotela eyi-prescribe ngalamazwi, ibhekwa njenge-“on-label” use. Nasi isibukiso esinemininingwane sokuthi i-Cymbalta isetshenziselwa ini ngokusho kwe-FDA.
Okunye okubalulekile kwe-Cymbalta ukwelashwa kwe-Major Depressive Disorder, isimo somzwa esingapheli esidlula nje ukuzizwa usizi. I-Cymbalta yokudumala isebenza ngokukusiza ukubuyisela ibhalansi yamachemikhali ebuchopho, kunciphisa izimpawu ezifana nosizi oluqhubekayo, ukulahlekelwa yisithakazelo kwimisebenzi, izinguquko ekudleni noma ekulaleni, kanye nemizwa yokuba nokungabi nalutho umthombo. Igunyaziwe kubantu abadala abane-MDD.
Kulabo abazwayo ukukhathazeka ngokweqile, okungapheli okunzima ukukulawula, i-Cymbalta yokukhathazeka ingaba yindlela ephumelelayo yokwelapha. Igunyazwe yi-FDA ukuphatha i-Generalized Anxiety Disorder kubantu abadala kanye nezingane ezineminyaka engu-7 nangaphezulu. Ngokuthonya i-serotonin ne-norepinephrine, i-Cymbalta ingasiza ukuthulisa uhlelo lwezinzwa, kunciphise izimpawu zomzimba nezingokwengqondo zokukhathazeka okungapheli.
Lapha yilapho isenzo esiyingqayizivele esiphindwe kabili se-Cymbalta sikhanya khona kakhulu. Izigidi zabantu abanesifo sikashukela baphathwa yimonakalo wezinzwa, ikakhulukazi ezinyaweni nasezandleni zabo, okungadala ukusha, ukubhinqa, noma ubuhlungu obubukhali. I-Cymbalta yobuhlungu bezintambo iyindlela yokuqala yokwelapha lesi simo ngoba isebenza ngaphakathi ohlelweni oluphakathi lwezinzwa ukuvimbela izimpawu zobuhlungu, inikeze impumuzo enkulu lapho izidambisi zobuhlungu ezijwayelekile zingase zingaphumeleli.
I-Fibromyalgia yisimo esiyinkimbinkimbi esingapheli esibonakala ubuhlungu obusakazekile emzimbeni, ukukhathala, izinkinga zokulala, nezinkinga zenkumbulo. Isizathu esiqondile asaziwa, kodwa kukholakala ukuthi sihilela indlela ubuchopho nomgogodla obucubungula ngayo izimpawu zobuhlungu. I-Cymbalta ye-fibromyalgia igunyaziwe kubantu abadala nezingane ezineminyaka eyi-13 nangaphezulu. Kukholakala ukuthi isiza ngokukhulisa amazinga ama-neurotransmitters anciphisa umuzwa wobuhlungu futhi athuthukise impilo jikelele ezigulini umthombo.
Ngaphezu kwezimo ezithile, i-Cymbalta igunyaziwe futhi ukwelapha ubuhlungu obungapheli bemisipha namathambo kubantu abadala. Lokhu kufaka ubuhlungu obude obubangelwa izimo ezifana nobuhlungu obungapheli beqolo kanye nobuhlungu ngenxa ye-osteoarthritis. Kulabo ziguli, i-Cymbalta inikeza indlela yokwelapha engasebenzisi i-opioid yokuphatha ubuhlungu obuvela emathanjeni, emisipheni, emagqabeni, namathambo.
Ungase umange ukuthola ukuthi odokotela bangakwazi ngokusemthethweni ukugunyaza imithi izimo abangagunyaziwe yi-FDA kuzo. Lokhu kubizwa nge-“off-label” prescribing, futhi kuyindlela ejwayelekile nenokubaluleka emculweni lapho umhlinzeki wezempilo ekholelwa, ngokususelwa ebufakazini besayensi nolwazi lwezempilo, ukuthi imithi ingazuzisa isiguli kwesinye isimo.
Kunezinketho eziningana zezinsiza ze-cymbalta ezingagunyaziwe ezikhombise ithemba ezifundweni zezokwelapha. Ezinye zalezi zihlanganisa:
Ayikho imithi engenazo izingozi ezingenzeka, futhi kubalulekile ukuba nombono ocacile wezinhlangothi ezingenzeka zomzimba. Ukuqonda lezi kungakusiza wena nodokotela wakho nenze isinqumo esinolwazi futhi niqaphe impilo yakho ngokucophelela ngesikhathi sokwelashwa. Izinhlangothi zomzimba ze-cymbalta zingahluka kusuka kokuncane nokwesikhashana kuya kokukhulu okudinga ukunakekelwa kwezimo eziphuthumayo.
Abantu abaningi banokuhlangabezana nezinhlangothi ezincane zomzimba lapho baqala ukusebenzisa i-Cymbalta, okuyinto evamise ukuncipha noma iphele lapho umzimba wabo ujwayela imithi. Lezi zingahlanganisa:
Kubalulekile futhi ukuphawula ukuthi izinguquko esisindweni (kokubili ukwanda nokuncipha) kanye nezinkinga zocansi, njengokuncipha kwe-libido noma ubunzima bokufika esiqongweni, yizinto ezingenzeka zezinhlangothi zomzimba ze-duloxetine okufanele kuxoxwe ngazo nodokotela wakho uma ziba yinkinga.
Noma kungavamile, ezinye zezinhlangothi zomzimba ze-duloxetine zinkulu futhi zidinga ukunakekelwa kwezimo eziphuthumayo. Thinta udokotela wakho noma ufune usizo oluphuthumayo uma uzwa:
Isixwayiso Sebhokisi Elimnyama le-FDA: Isaziso Esibalulekile
I-FDA ikhiphe uhlobo lwayo lwesixwayiso eserious kakhulu, i-“black box warning,” ye-Cymbalta kanye namanye ama-antidepressants. Ikhombisa ingozi eyandisiwe yokucabanga nokuziphatha kokuzibulala ezinganeni, kusanda kukhula, kanye nabantu abasebancane (kuze kube neminyaka engama-24), ikakhulukazi phakathi nezinyanga zokuqala zokwelashwa noma ngemuva kokushintsha kwe-cymbalta dosage umthombo.
Kubaluleke kakhulu ukuthi iziguli kuleli qembu leminyaka, kanye nemindeni yazo nabagadi bazo, ziqaphele noma yikuphi ukwanda kokudumala, izinguquko ezingajwayelekile ekuziphatheni, noma ukuvela kokucabanga kokuzibulala. Noma yiziphi izinguquko ezikhathazayo kufanele zibikezwe kumhlinzeki wezempilo ngokushesha.
Ukuqinisekisa ukuphepha kwakho, kubalulekile ukuba nengxoxo evulekile neqotho nodokotela wakho mayelana nomlando wakho ogcwele wezempilo ngaphambi kokuqala ukwelashwa. Nansi eminye imininingwane ebalulekile okufanele uyixoxe:
Uma wena nodokotela wakho ninquma ukuthi sekuyisikhathi sokuyeka ukusebenzisa i-Cymbalta, awukwazi nje ukuyeka “ngokushona”. Ukuyeka imithi ngokuzumayo kungaholela esimo esibizwa nge-Discontinuation Syndrome, esivame ukubizwa nge-cymbalta withdrawal. Izimpawu zingaba nzima kakhulu futhi ngezinye izikhathi zibe zimbi.
Izimpawu ezijwayelekile ze-cymbalta withdrawal zihlanganisa:
Ukugwema lokhu, udokotela wakho uzodala uhlelo lokuncishiswa, oluhlanganisa ukunciphisa kancane kancane i-cymbalta dosage yakho phakathi nesikhathi samaviki noma izinyanga. Lokhu kuvumela ubuchopho nomzimba wakho ukuthi bajwayele kancane kancane, kunciphisa ingozi yezimpawu ezinkulu zokuhoxa. Ungalokothi uzame ukushintsha isilinganiso sakho noma uyeke ukusebenzisa i-Cymbalta ngaphandle kokuqondiswa kwezempilo.
Uhlu oluhlukahlukene lwe-cymbalta uses lwenza lube yithuluzi elibalulekile lokwelapha izimo eziningi ezinzima, kusuka ezingeni eliphansi lokudumala kuya ezibuhlungwini obungapheli be-fibromyalgia. Njenge-SNRI, ikhono layo eliyingqayizivele lokuthonya kokubili i-serotonin ne-norepinephrine liyivumela ukuthi iphathe kahle kokubili imizwa nobuhlungu.
Noma kunjalo, amandla ayo kufanele abekwe eceleni ngesibindi esinempilo ngezinhlangothi ezingenzeka nezingozi. Uhambo oluphumelelayo lokwelashwa luthembele ebambiswaneni eliqinile phakathi kwakho nomhlinzeki wakho wezempilo. Ngokuba nolwazi oluhle, ukuqaphela impilo yakho, nokugcina ukuxhumana okuvulekile, ningasebenzisana ukuze ninqume ukuthi izinsiza eziningi ze-duloxetine uses zilungele izidingo zakho zempilo.
Isaziso: Lesi sihloko senzelwe izinjongo zolwazi kuphela futhi asikwazi ukubhekwa njengeseluleko sezokwelapha. Ulwazi oluqukethwe lapha akulona isikhundla futhi akufanele ngaso sonke isikhathi kuthenjwe kuso seluleko sezokwelapha esiqeqeshiwe. Njalo khuluma nodokotela wakho ngobungozi nezinzuzo zanoma yikuphi ukwelashwa.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.